Nicotinamide for skin-cancer chemoprevention

New England Journal of Medicine

Volumn 374, Issue 8, 2016, Pages 789-

  Zhao, Yi ^a  

^a BEIJING TSINGHUA CHANGGUNG HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINAMIDE; PLACEBO; VITAMIN B COMPLEX;

ACTINIC KERATOSIS; CANCER PREVENTION; CHEMOPROPHYLAXIS; DRUG EFFICACY; DRUG SAFETY; HUMAN; KIDNEY TRANSPLANTATION; LETTER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SKIN CANCER; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; FEMALE; KERATOSIS, ACTINIC; MALE; SKIN NEOPLASMS;

CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; KERATOSIS, ACTINIC; MALE; NIACINAMIDE; SKIN NEOPLASMS; VITAMIN B COMPLEX;

EID: 84960951703     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1514791     Document Type: Letter

References (1)

1. Chen AC, Martin AJ, Choy B, et al. A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention. N Engl J Med 2015;373:1618-26.